[Form 4] Franklin Covey Company Insider Trading Activity

Rhea-AI Filing Summary

Franklin Covey Co. (NYSE: FC) – Form 4 insider filing

Chief Operating Officer Colleen D. Dom reported the acquisition of 1,526 common shares on 11-Jul-2025. The shares were received at $0.00 per share under the company’s FY25 long-term incentive plan (LTIP), which is scheduled to vest in three tranches during Oct 2025, Oct 2026, and Oct 2027. Following the grant, Dom’s direct beneficial ownership increased to 57,510 common shares. No derivative securities were involved and no sales were disclosed.

The filing signals continued equity alignment between the COO and shareholders, but the size of the grant (~1.5k shares) is modest relative to Franklin Covey’s average daily trading volume and total shares outstanding, suggesting limited market impact.

Positive

• Insider ownership increases: COO now holds 57,510 shares after receiving 1,526 LTIP shares, strengthening management-shareholder alignment.

Negative

• None.

Insights

Financial Analyst

TL;DR: Small LTIP share grant to COO; positive for alignment, limited market impact.

The Form 4 shows a routine LTIP grant of 1,526 shares to COO Colleen Dom at no cost, raising her stake to 57,510 shares. As no shares were sold, the action is a non-cash, non-dilutive event that marginally tightens executive-shareholder alignment. The volume is immaterial versus FC’s float, so price impact should be negligible. Overall, the disclosure is neutral-to-slightly positive from a governance standpoint.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dom Colleen D

(Last) (First) (Middle)

2200 WEST PARKWAY BLVD

(Street)

SALT LAKE CITY UT 84119

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FRANKLIN COVEY CO [ FC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	07/11/2025		A		1,526(1)	A	$0	57,510	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. FY25 LTIP, third vesting Oct 2025, Oct 2026, Oct 2027.

	Stephanie King, Attorney-in-Fact	07/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Franklin Covey's COO acquire according to the Form 4?

Colleen D. Dom acquired 1,526 Franklin Covey common shares on 11-Jul-2025 via the FY25 LTIP.

Was the transaction a purchase or a grant?

It was an LTIP grant at $0.00 per share, not an open-market purchase.

How many Franklin Covey shares does the COO now own?

After the grant, the COO directly owns 57,510 common shares.

Were any derivative securities involved in this filing?

No, the Form 4 shows no derivative securities acquired or disposed of.

What is the vesting schedule for the granted shares?

According to the footnote, the FY25 LTIP shares vest in October 2025, 2026, and 2027.